Drug Type Antibody drug conjugate (ADC) |
Synonyms |
Target |
Mechanism PSMA inhibitors(Prostate-specific membrane antigen inhibitors), STEAP1 inhibitors(Six-transmembrane epithelial antigen of the prostate 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic castration-resistant prostate cancer | Preclinical | CN | 22 Mar 2024 |